Records containing: Hemophilia A
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-06-14Prevalence and Consequences of Hepatitis Delta Virus Infection in Hemophiliacs
-
CLINICAL_TRIALS study record update · 2016-05-13ClinicalTrials.gov study NCT00005518
-
CLINICAL_TRIALS study record update · 2016-05-12Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
-
CLINICAL_TRIALS study record update · 2016-04-29Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia
-
CLINICAL_TRIALS study record update · 2016-04-04Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-03-02Phase II Biologic Effects Study of Recombinant Interleukin-11 (rhIL-11, Neumega) in Subjects With Moderate or Mild Hemophilia A, or Von Willebrand Disease Unable to Use DDAVP
-
CLINICAL_TRIALS study record update · 2016-02-17Single Dose, Open-label, Randomized, Crossover Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate
-
CLINICAL_TRIALS study record update · 2015-12-03Content and Psychometric Validation Study of the Colorado Adult Joint Assessment Scale (CAJAS) in Subjects With Moderate to Severe Hemophilia A Treated on Prophylaxis
-
CLINICAL_TRIALS study record update · 2015-08-17Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha 'Registered' In Subjects With Hemophilia A
-
CLINICAL_TRIALS study record update · 2015-07-17Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis
-
CLINICAL_TRIALS study record update · 2015-06-23IMMUNE TOLERANCE INDUCTION, BY FACTOR VIII CONCENTRATE CONTAINING VON WILLEBRAND FACTOR, IN SEVERE OR MODERATE HAEMOPHILIA A PATIENTS WITH INHIBITORS
-
CLINICAL_TRIALS study record update · 2015-04-20Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery - NO PEACKS
-
CLINICAL_TRIALS study record update · 2015-03-20A European, Prospective, Non-Interventional Study to Assess Health Related Quality of Life and to Identify Key Transitional Life Events in Patients With Moderate or Severe Haemophilia A Using Helixate NexGen
-
CLINICAL_TRIALS study record update · 2015-02-13Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2015-01-19Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
-
CLINICAL_TRIALS study record update · 2015-01-05Routine Prophylaxis Treatment Versus On-demand Treatment for Children With Severe Hemophilia A: Comparison of All Bleeding Events in Chinese Hemophilia Patients
-
CLINICAL_TRIALS study record update · 2014-12-31Prevalence and Epitope Specificity of Non-neutralizing Antibodies in Haemophilia A Patients Without Inhibitors, Immunogenicity of B Domain: A Prospective Study
-
CLINICAL_TRIALS study record update · 2014-12-18Assessment of the Risk of Inhibitor Formation in Subjects With Severe Hemophilia A When Switched From a Replacement Therapy With a rFVIII Produced by a Chinese Hamster Ovary (CHO) Cell Line to a rFVIII Produced by a Baby Hamster Kidney (BHK) Cell Line (Kogenate® FS).
-
CLINICAL_TRIALS study record update · 2014-12-17Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Patients With Congenital Hemophilia A With Factor VIII Inhibitors
-
CLINICAL_TRIALS study record update · 2014-12-12An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB031, in the Prevention and Treatment of Bleeding Episodes in Pediatric Subjects With Hemophilia A
-
CLINICAL_TRIALS study record update · 2014-11-18A Randomized, Double-blind, Cross-over Study to Determine the Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 in Previously Treated Patients With Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2014-11-04Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2014-10-31Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A.
-
CLINICAL_TRIALS study record update · 2014-10-09A Phase 3b Clinical Study to Assess Whether Regular Administration of ADVATE in the Absence of Immunological Danger Signals Reduces the Incidence Rate of Inhibitors in Previously Untreated Patients With Hemophilia A
-
CLINICAL_TRIALS study record update · 2014-09-01A Postauthorization Safety Surveillance Study Of Patients Switching To ReFacto AF From ReFacto Or Other Factor VIII Products In Usual Care Settings